Your browser doesn't support javascript.
loading
Overcoming Primary Resistance to PD-1 Inhibitor With Anti-PD-L1 Agent in Squamous-Cell NSCLC: Case Report.
Gelsomino, Francesco; Di Federico, Alessandro; Filippini, Daria M; Dall'Olio, Filippo G; Lamberti, Giuseppe; Sperandi, Francesca; Balacchi, Caterina; Brocchi, Stefano; Ardizzoni, Andrea.
Affiliation
  • Gelsomino F; Medical Oncology Unit, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
  • Di Federico A; Medical Oncology Unit, Department of Experimental, Diagnostic and Specialty Medicine University of Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
  • Filippini DM; Medical Oncology Unit, Department of Experimental, Diagnostic and Specialty Medicine University of Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy. Electronic address: d.m.filippini@gmail.com.
  • Dall'Olio FG; Medical Oncology Unit, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
  • Lamberti G; Medical Oncology Unit, Department of Experimental, Diagnostic and Specialty Medicine University of Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
  • Sperandi F; Medical Oncology Unit, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
  • Balacchi C; Diagnostic and Interventional Radiology Unit, Department of Diagnostic and Preventive Medicine, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
  • Brocchi S; Diagnostic and Interventional Radiology Unit, Department of Diagnostic and Preventive Medicine, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
  • Ardizzoni A; Medical Oncology Unit, Department of Experimental, Diagnostic and Specialty Medicine University of Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy; Medical Oncology Unit, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
Clin Lung Cancer ; 21(2): e45-e48, 2020 03.
Article in En | MEDLINE | ID: mdl-31902695
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Antibodies, Monoclonal, Humanized / B7-H1 Antigen / Programmed Cell Death 1 Receptor / Nivolumab / Immune Checkpoint Inhibitors Type of study: Prognostic_studies Limits: Aged / Female / Humans Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Antibodies, Monoclonal, Humanized / B7-H1 Antigen / Programmed Cell Death 1 Receptor / Nivolumab / Immune Checkpoint Inhibitors Type of study: Prognostic_studies Limits: Aged / Female / Humans Language: En Year: 2020 Type: Article